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Polybrominated diphenyl ethers (PBDEs) are ﬂame retardants widely used in electronic and domestic goods. These
persistent pollutants are present in the environment and in humans, and their toxicological properties are of growing
concern. PBDEs can be metabolised into compounds suspected to be responsible for their toxicity. These metabolites
have been characterised quite well in rodents and ﬁsh, but available information in humans remains scarce. For their
identiﬁcation, an efﬁcient method for the simultaneous analysis of PBDEs, hydroxylated PBDEs (OH-PBDEs), and
other PBDE metabolites in a single run was needed and has been developed in this work. Atmospheric pressure
ionisation modes were compared, and Atmospheric Pressure Photo-Ionization (APPI) was selected. After careful
setting of APPI parameters such as dopant and operating temperature, the optimised method was based on APPI
ionization coupled to High-Resolution Mass Spectrometry operating in the full scan mode at a resolution of
60 000. This provided excellent sensitivity and speciﬁcity, allowing the discrimination of signals which could not
be resolved on a triple quadrupole used as a reference. The full-scan high-resolution acquisition mode allowed
monitoring of both parent PBDEs and their metabolites, including hydroxylated PBDEs, with detection limits
ranging from 0.1 pg to 4.5 pg injected on-column based on the investigated standard compounds. The method was
applied to the study of BDE-47 metabolism after incubation with human primary cultures of hepatocytes, and proved
to be efﬁcient not only for monitoring the parent compound and expected hydroxylated metabolites, but also for the
identiﬁcation of other non-targeted metabolites. In addition to hydroxy-BDE-47, several conjugated metabolites
could be located, and the formation of a dihydrodiol derivative was evidenced for the ﬁrst time in the case of PBDEs
in this work. Copyright © 2012 John Wiley & Sons, Ltd.
(wileyonlinelibrary.com) DOI: 10.1002/rcm.6136Polybrominated diphenyl ethers (PBDEs) are additive bromi-
nated ﬂame retardants (BFR) used to ﬁreproof plastics and
textiles. They are commonly used in the manufacture of
electric and electronic appliances, as well as transportation
and construction foams, with the aim of decreasing ﬁre risk.
Three commercial mixtures of PBDEs were originally manu-
factured. The ’deca-mix’, which mainly contains deca-BDE
(BDE-209), is now by far the most commonly used, and the
most efﬁcient mixture. The production and/or the use of the
two other mixtures, namely ’penta-mix’ and ’octa-mix’, have
been phased out in several countries. PBDEs were classiﬁed
as Persistent Organic Pollutants (POPs) in 2009 by the
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59The presence of PBDEs has been demonstrated in all
environmental compartments, including sediments and dust.
PBDEs are both persistent and bioaccumulative.[4–6] The
occurrence of PBDEs in humans has been reported in several
studies, with the predominance of congeners 47, 99, 100, 153,
154 and 183. A study focused on both indicators and highly
brominated PBDEs has indicated that tri- to deca-BDEs are
present in samples collected from the French population,
including adipose tissue, maternal milk, serum and cord
serum, with higher amounts of highly brominated PBDEs
(especially BDE-207 and -209) compared to the more
commonly monitored indicator PBDEs (i.e. BDE-28, -47, -99,
-100, -153, -154, -183) in serum samples.[7,8] The toxic effects
of PBDEs have only partly been characterised so far. They
appear to rely both on direct mechanisms and on the capabi-
lity of PBDEs to behave as endocrine disruptors, as high-
lighted by recent studies.[9,10] Among others, it was shown
that a prenatal exposure of rodents to PBDEs during criticalCopyright © 2012 John Wiley & Sons, Ltd.
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600periods of the brain development can result in decreased
learning and memory capacities, as well as modiﬁed
behaviour, which persist in adulthood.[11,12] Those neurotoxic
effects might be linked with the capability of PBDEs to
disrupt thyroid hormones homeostasis.[13,14] Some studies
also established that PBDEs can alter some sexual characteris-
tics in male and female rats, and modify the metabolism of
steroid hormones.[15,16] The biological effects of PBDEs could
result, at least in part, from the formation of bioactive
metabolites. As ﬁrst demonstrated by Meerts et al.,[17] some
PBDE metabolites, especially hydroxylated metabolites
(OH-PBDEs) of tetra-BDE such as OH-BDE-47, express a
strong afﬁnity for thyroid hormone transporters TTR and
TBG.[18] They can also activate estrogen receptor-a.[19] More-
over, a few studies have already established the presence of
several PBDE metabolites in human serum and maternal
milk.[20–22] Though BDE-209 is by far the main PBDE produced
and used nowadays, it is well known that PBDEs can readily
debrominate in the environment through photolytic mecha-
nisms, producing a variety of lower brominated analogues.[23,24]
In addition, PBDEs have been shown to be metabolised into
lower brominated analogues and/or oxidated metabolites, in
ﬁsh as well as in rats.[25–28] Human cells as well as liver micro-
somes are also able to metabolise PBDEs through oxidation,
debromination, methoxylation, and through the cleavage of
the ether bond of the molecule leading to bromophenols.[29–31]
However, knowledge on the metabolism of PBDEs by human
remains sparse and efﬁcient tools allowing a deep investigation
of both those apolar compounds and their polar metabolites
are still needed.
Currently, the analysis of PBDEs and OH-PBDEs is most
often carried out separately using gas chromatography/mass
spectrometry (GC/MS), although derivatisation may be
necessary for the analysis of OH-PBDEs. The main advantages
of GC/MS are the ﬁne chromatographic resolution of PBDEs
congeners, and its great sensitivity, especially when using
Electron Capture Negative Ionisation (ECNI). However, GC/
ECNI-MS is poorly speciﬁc, since the monitored ions are solely
bromine ions. Electron ionisation provides more speciﬁcity,
with the formation of [M]+. and [M–Br2]
+. ions, but this techni-
que is less sensitive (especially for highly brominated
PBDEs).[32] Another problem is the thermal degradation of
highly brominated PBDEs. To avoid such problems, the analy-
sis of PBDEs by liquid chromatography/mass spectrometry
(LC/MS) using Atmospheric Pressure Photo-Ionisation (APPI)
has been proposed.[33] The behaviour of PBDEs towards APPI
processes has been studied in detail,[34] and several speciﬁc
methods have been developed for the study of PBDEs in house
dust,[35,36] water,[37] and ﬁsh samples.[38] Two studies haveFigure 1. Generic structure of PB
wileyonlinelibrary.com/journal/rcm Copyright © 2012 John Wicompared the performances of Atmospheric Pressure Chemical
Ionisation (APCI) and APPI for the analysis of PBDEs in
sewage sludge[39] and in ﬁsh and water.[38,40] Unlike PBDEs,
OH-PBDEs can be analysed by Electrospray Ionisation
(ESI)[41–43] or APCI.[44,45]
In the present study, we developed a LC/MS method
allowing for the ﬁrst time the simultaneous detection and
identiﬁcation of PBDEs, and their metabolites (with special
emphasis on the bioactive OH-PBDEs), with the aim of
applying this method to PBDE metabolism studies. The
development was carried out on a set of commercially
available PBDEs and OH-PBDEs, whose structures and
estimated logP values[46] are presented in Fig. 1 and Table 1,
respectively. We ﬁrst compared ESI, APCI and APPI as ionisa-
tion means for PBDEs and OH-PBDEs. Based on our previous
work,[33,34] APPI of PBDEs and OH-PBDEs was then studied,
in order to set up the optimal MS acquisition parameters. A
highly sensitive and speciﬁc method based on high-resolution
MS (HRMS) on a hybrid LTQ-Orbitrap was developed and its
performance compared to a targeted multiple reaction
monitoring (MRM) approach on a triple quadrupole taken
as a reference. Particular attention was also paid to the LC
separation of PBDEs and OH-PBDEs. Finally, the method
was applied to biological samples in the framework of
metabolic studies, through the analysis of culture media
extracts obtained after incubation of BDE-47 with human
primary cultures of hepatocytes.EXPERIMENTAL
Chemicals
Standards of OH-PBDEs (3-OH-BDE-47, 4’-OH-BDE-49, 5-
OH-BDE-47, 6-OH-BDE-47, 5’-OH-BDE-99, 3-OH-BDE-100,
3’-OH-BDE-154, 6-OH-BDE-180, 4-OH-BDE-187, 4-OH-BDE-
188 and 4’-OH-BDE-201) were from Accustandard (New
Haven, CT, USA), and standards of PBDEs (BDE-47, -99,
-100, -153, -154, -183, -184, -201, -202, -204, -206, -207, -208,
-209) from Wellington Laboratories (Guelph, ON, Canada).
All solvents used for HPLC were HPLC grade solvents from
Scharlau (Barcelona, Spain). Methoxylated tetra-BDEs and
bromophenols were synthesised at the laboratory using
previously published procedures.[47] Radio-labelled BDE-47
was synthesised from ring-[14C]-diphenyl ether (Izotop,
Institute of Isotopes Co. Budapest, Hungary; speciﬁc activity:
5.28 MBq.mg1). Partial bromination of [14C]-diphenyl ether
was achieved with iron dibromide. BDE-47 was then puriﬁed
by HPLC, using a Jasco HPLC system composed of a HPLC
pump series PU-980 and a UV detector series UV-975 (Merck,DEs and hydroxylated PBDEs.
ley & Sons, Ltd. Rapid Commun. Mass Spectrom. 2012, 26, 599–610
Table 1. Studied PBDEs and OH-PBDEs and estimation of their logP values
Compounds IUPAC name Bromine substitution logP
Tetra-BDE BDE-47 2,2’,4,4’ 6,40 0,43
Penta-BDEs BDE-99 2,2’,4,4’,5 7,05 0,57
BDE-100 2,2’,4,4’,6 7,07 0,59
Hexa-BDEs BDE-153 2,2’,4,4’,5,5’ 7,69 0,75
BDE-154 2,2’,4,4’,5,6’ 7,71 0,76
Hepta-BDEs BDE-183 2,2’,3,4,4’,5’,6 8,30 0,93
BDE-184 2,2’,3,4,4’,6,6’ 8,32 0,94
Octa-BDEs BDE-201 2,2’,3,3’,4,5’,6,6’ 8,87 1,12
BDE-202 2,2’,3,3’,5,5’,6,6’ 8,85 1,12
BDE-204 2,2’,3,4,4’,5,6,6’ 8,89 1,13
Nona-BDEs BDE-206 2,2’,3,3’,4,4’,5,5’,6 8,41 0,96
BDE-207 2,2’,3,3’,4,4’,5,6,6’ 8,19 0,84
BDE-208 2,2’,3,3’,4,5,5’,6,6’ 8,17 0,84
Deca-BDE BDE-209 2,2’,3,3’,4,4’,5,5’,6,6’ 8,77 1,04
Hydroxylated tetra-BDEs 3-OH-BDE-47 2,2’,4,4’ 5,99 0,57
5-OH-BDE-47 2,2’,4,4’ 6,02 0,59
6-OH-BDE-47 2,2’,4,4’ 5,98 0,56
4’-OH-BDE-49 2,2’,4,5’ 5,96 0,56
Hydroxylated penta-BDEs 5’-OH-BDE-99 2,2’,4,4’,5 6,68 0,71
3-OH-BDE-100 2,2’,4,4’,6 6,70 0,74
Hydroxylated hexa-BDEs 3’-OH-BDE-154 2,2’,4,4’,5,6’ 7,34 0,89
Hydroxylated hepta-BDEs 6-OH-BDE-180 2,2’,3,4,4’,5,5’ 7,98 1,05
4-OH-BDE-187 2,2’,3,4’,5,5’,6 7,911,03
4-OH-BDE-188 2,2’,3,4’,5,6,6’ 7,93 1,04
Hydroxylated octa-BDEs 4’-OH-BDE-201 2,2’,3,3’,4,5’,6,6’ 8,511,21
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60Nogent-sur-Marne, France) coupled to a model 202 (Gilson,
Roissy, France) fraction collector. The structure and purity
(>99%) of synthesised BDE-47 (speciﬁc activity: 1.78 Mbq.
mg–1) were checked by MS and NMR.
Metabolism studies
Hepatocytes were obtained from three human donors (two
women: 82 and 31 years old and one man: 64 years old) and
were treated separately. Human liver biopsies (resected from
secondary tumors and cryopreserved after procurement)
were isolated, cryopreserved and cultivated as previously
described.[48] After a speciﬁc and actually conﬁdential
freeze-thaw protocol in Leibowitz L-15 medium supplemen-
ted with FBS, insulin and DMSO (progressively decreased
in further steps), around 400 000 human hepatocytes were
seeded in 12-well plates in L-15 supplemented with FBS
culture medium. They were allowed to grow during 24 h at
37C and under 5% CO2. Then, medium was removed and
replaced by 1 mL of William’s E medium with Glutamax
supplemented with 0.5% penicillin/streptomycin and 0.1
UI/mL insulin, and incubations were carried out for 24 h at
37C under 5% CO2 in the presence of 1 mM or 5 mM radio-
labelled BDE-47 (diluted in 5 mL DMSO). At the end of the
incubation period, culture media were collected, and cell
contents were extracted using acetonitrile/water (50:50, v/v).
Both fractions were stored at 20C until analysis.
Sample preparation for MS analysis
Culture media were treated using methanol (1:3, v/v) for
protein precipitation, and were then evaporated to dryness
under a nitrogen stream. Each extract was individually
retaken in 100 mL methanol and submitted to HPLCCopyright © 2012 JRapid Commun. Mass Spectrom. 2012, 26, 599–610separation and fraction collection (1 min fractions) used as a
cleanup step with the aim of eliminating potential culture
media interfering compounds. Radioactive fractions were
pooled, evaporated under a nitrogen stream and redissolved
in 25 mL methanol for LC/APPI-HRMS injection.LC/MS
LC/HRMS experiments were carried out on a LTQ-Orbitrap
XL mass spectrometer (Thermo Fisher Scientiﬁc, Les Ulis,
France) coupled to an Ultimate 3000 LC System (Dionex,
Voisins le Bretonneux, France). The Orbitrap cell was
operated in the full-scan mode at a resolution power of 60
000. A TSQ Quantum triple quadrupole mass spectrometer
(Thermo Fisher Scientiﬁc, Les Ulis, France) coupled to an
Accela LC system was used to carry out MRM LC/MS/MS
experiments. Both devices were operated in the negative
APPI, APCI or ESI ionisation modes. APCI was operated
with a discharge current of 8 mA. A Syagen APPI source
(Thermo Fisher Scientiﬁc, Les Ulis, France) operating with a
krypton discharge lamp was used for APPI. APPI operating
parameters were as follows: sheath gas (N2), 70 arb. units;
and auxiliary gas (N2), 20 arb. units.
Development steps were completed on the triple quadrupole
instrument and later conﬁrmed on the Orbitrap mass spectro-
meter. The inﬂuence of APPI key operating parameters on the
ionisation was studied by carrying out ﬁve injections of a
mixture of PBDEs/OH-PBDEs directly into the source by FIA
for each condition tested. Acetone, anisole and toluene were
tested as dopants, in 5, 10 and 15% proportions. The dopant
was introduced either by post-column addition or directly as
LCmobile phase component. The impact of the heated transfer
capillary and the nebuliser temperatures on the intensity ofwileyonlinelibrary.com/journal/rcmohn Wiley & Sons, Ltd.
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602diagnostic ions for PBDEs and OH-PBDEs was studied from
200C to 350C and 200C to 400C, respectively (50C steps
in both cases).
U-HPLC columns used were an Hypersil Gold C18 column
(100 2.1 mm, 1.9 mm) and an Hypersil Gold PFP column
(100 2.1 mm, 1.9 mm) from Thermo Fisher Scientiﬁc (Les
Ulis, France). Optimised LC separation was achieved on the
PFP column at 40C, at a ﬂow rate of 250 mL.min–1 with a
multistep gradient of mobile phase A: water/methanol/
acetone (80:10:10, v/v/v) and mobile phase B: methanol/
acetone (90:10, v/v). Initial conditions were A:B 70:30 v/v
held for 1 min followed by a 12 min gradient from A:B
70:30 v/v to 30:70 v/v, then a 13 min gradient from A:B
30:70 v/v to 25:75 v/v and a ﬁnal 1 min gradient from
A:B 25:75 v/v/ to 100% B, held for 5 min.RESULTS AND DISCUSSION
Ionisation mode
Comparison of APPI, APCI and ESI modes
The performance of the three ionisation modes for LC/MS,
i.e. ESI, APCI and APPI, was ﬁrst compared. As expected,
ESI was only suitable for OH-PBDEs, and presented sensitiv-
ities in the low pg range in HRMS, comparable to the values
generally reported for analysis of OH-PBDEs by LC/ESI-MS/
MS.[41–43] This good sensitivity can be attributed, at least in
part, to the soft ionisation process of ESI, generating almost
only quasimolecular ions. APCI is suitable for analysis of
PBDEs and OH-PBDEs. They were ionised in a similar way
compared to APPI, and in agreement with other works.[39,40]
For PBDEs, the main ions formed were [C6BrxH5-xO]
– ions,
whereas [M–Br]– or [M–Br–xHBr]– ions were produced in a
lesser extent (data not shown). OH-PBDEs were ionised as
[M–H]– ions and their subsequent debromination ions. Con-
cerning sensitivity considerations, APCI gave slightly less sensi-
tive detection limits than APPI for both families of compounds
with detection limits ranging from 30 to 60 pg injected on the
LC column (data not shown). This is in agreement with the
instrument detection limits reported by Zhou et al.[38,40] who
developed both LC/APCI and LC/APPI methods for BFR anal-
ysis on a triple quadrupole instrument. Mascolo et al. also com-
pared ESI, APCI and APPI as ionisation sources for LC/MS
PBDE analysis, and found that APPI gave the best signal
intensities although APCI was less sensitive to ion suppres-
sion effects when analysing complex matrix samples.[39]
Therefore, APPI ionisation mode was chosen for its
sensitivity and informative ionisation pattern which will be
discussed later. Both the positive and negative APPI modes
were tested. As expected, the positive mode yielded weak
current ions, only for lowly brominated PBDEs, in good
agreement with previous reports.[33,39] The negative ionisation
mode showed a much better sensitivity and was thus selected.
APPI key parameters
APPI operating parameters were set up with emphasis on the
dopant and the source operating temperatures known to
represent key parameters for efﬁcient and sensitive APPI-
based methods. Three dopants (i.e. acetone, anisole and
toluene) were tested and led to similar ionisation patternswileyonlinelibrary.com/journal/rcm Copyright © 2012 John Wiand signal intensities. By contrast, the proportion of dopant
added to the mobile phase was found to inﬂuence the signal
intensity and should be kept above 5% (data not shown). These
results are consistent with previously publishedworkswhere 10
to 20% of toluene[35,36,39] or acetone[37,38] were used. The adjunc-
tion of the dopant directly into the LCmobile phases rather than
by post-column addition provided better signal-to-noise (S/N)
ratios, likely due to a more homogeneous distribution of the
dopant when entering the atmospheric pressure ionisation
chamber, in agreement with previous observations.[37,49]
Operating temperatures also greatly inﬂuenced the
ionisation of PBDEs. After careful optimisation of both the
nebulizer and capillary temperatures, results indicate that
the capillary temperature should not be set above 250C to
achieve the best intensity for all diagnostic ions. Nebuliser
temperature was found to have a qualitative inﬂuence on
ionisation. High temperatures (from 300 to 350C) promoted
the formation of cleaved [C6BrxH5-xO]
– ions over [M–Br]– ions
for PBDEs and to a lesser extent for OH-PBDEs (data not
shown). As expected this trend was stronger for nona- and
deca-BDEs, which are known to be thermolabile.[32] In
the present work, heated transfer capillary and nebulizer
temperatures were set at 250C and 300C, respectively.
APPI ionisation pattern
In order to select appropriate signals to work on, the ionisa-
tion patterns of the studied PBDEs and OH-PBDEs (Table 1)
were examined. In previous works reporting the use of
APPI-MS for the analysis of PBDEs, phenoxyde [M–Br+O]–
ions were always observed, sometimes with additional
debromination products.[33–39] In this study, using the
IonMax APPI source and acetone as the doping agent, tetra-
and penta-BDEs yielded [M–Br+O]– ions (data not shown)
whereas [M–Br]– ions were predominantly observed for
hepta- to nona-brominated congeners, as shown on the mass
spectra presented in Fig. 2. For almost all compounds, the forma-
tion of [C6BrxH5-xO]
– bromophenoxide ions, resulting from the
breakdown of the PBDE ethereal bond, was observed. Usually,
such fragment ions are only observed for high molecular weight
PBDEs, and can even represent the predominant ions in the case
of deca-BDE[33,35,38,39] and nona-BDEs.[35] The differences
observed in the present study may be attributed to the use of a
different ionisation source, as it is nowwell known that the source
conﬁguration can play on the ionisation pattern of PBDEs.[36,49]
The main APPI-produced ions from OH-PBDEs are listed
in Table 2. [M–Br–HBr]– were the major APPI-produced ions,
except in the case of the two congeners hydroxylated at
position 6 (namely 6-OH-BDE-47 and 6-OH-BDE-180)
which yielded [M–Br]– ions as the base peak. However, in
the case of hydroxylated tetra-BDEs, the intensities of
signals arising from the deprotonated [M–H]– ions were
more signiﬁcant. Figure 3 represents the APPI-MS spectra
of the four hydroxylated tetra-BDEs studied in this work.
Each isomer shows a different and thus speciﬁc ionisation
pattern. As already mentioned, 6-OH-BDE-47 was mainly
ionised into the corresponding [M–Br]– ion, whereas 4’-OH-
BDE-49 was mainly ionised by deprotonation, giving the
corresponding [M–H]– ion. In the case of 5-OH-BDE-47, the
[M–H]– ion intensity was ca. 60% and the [M–H–HBr]– ion
represented the base peak, and 3-OH-BDE-47 predominantly
led to the [M–Br–HBr]– ion.ley & Sons, Ltd. Rapid Commun. Mass Spectrom. 2012, 26, 599–610
Table 2. Main ions observed from APPI ionisation of OH-PBDE
Congeners
[M–H]– [M–Br]–
calc. m/z, Rel. Int %. calc. m/z, Rel.
3-OH-BDE-47 496.70285 55 418.79234
5-OH-BDE-47 496.70285 60 418.79234
6-OH-BDE-47 496.70285 20 418.79234
4’-OH-BDE-49 496.70285 100 418.79234
5’-OH-BDE-99 574.61337 10 496.70285
3-OH-BDE-100 574.61337 15 496.70285
3’-OH-BDE-154 652.52388 15 574.61337
6-OH-BDE-180 730.43439 5 652.52388
4-OH-BDE-187 730.43439 15 652.52388
4-OH-BDE-188 730.43439 5 652.52388
4’-OH-BDE-201 808.34490 2 730.43439
Figure 2. Negative APPI mass spectra of (a) 3-OH-BDE-47,
(b) 3-OH-BDE-100, (c) 6-OH-BDE-180, (d) 4’OH-BDE-201,
(e) BDE-184, (f) BDE-202, (g) BDE-207, and (h) BDE-209
obtained for the injection of 1 ng PBDE on-column.
Determination of PBDEs and their metabolites
Copyright © 2012 JRapid Commun. Mass Spectrom. 2012, 26, 599–610In anticipation of our application to a metabolism study,
the ionisation of other potential metabolites of PBDEs was
also assessed, with particular emphasis on bromophenols
and methoxylated PBDEs derived from BDE-47. Those
compounds were ionisable by APPI, and yielded speciﬁc
mass spectra. Bromophenols were ionised as [M–H]– ions,
corresponding to the [C6BrxH5-xO]
– ions of PBDEs. As for
PBDEs, APPI mass spectra of methoxylated tetra-BDEs
derived from BDE-47 displayed [M–Br]– as major ions
together with [M–Br+O]–, [M–Br–CH3]
– ions and other frag-
ment ions arising from subsequent losses of HBr as minor
ions (data not shown).
Optimisation of LC separation
The LC separation of congeners of PBDEs and OH-PBDEs
represents a real analytical challenge since PBDE mixtures
usually contain several positional isomers. As indicated in
Table 1, the logP values estimated for these compounds show
that they are highly lipophilic and that, despite the adjunction
of a hydroxyl group, the hydroxylated PBDE metabolites are
only slightly less lipophilic than the parent compounds. It can
be deduced from these observations, as well as froms
[M–H–HBr]– [M–Br–HBr]–
Int %. calc. m/z, Rel. Int %. calc. m/z, Rel. Int %.
5 416.77669 50 338.86618 100
3 416.77669 100 338.86618 90
100 416.77669 15 338.86618 15
45 416.77669 45 338.86618 60
2 494.68720 40 416.77669 100
4 494.68720 40 416.77669 100
10 572.59772 2 494.68720 100
100 650.50823 0 572.59772 30
70 650.50823 0 572.59772 100
10 650.50823 0 572.59772 100
25 728.41874 0 650.50823 100
Figure 3. Negative APPI mass spectra of (a) 3-OH-BDE-47,
(b) 5-OH-BDE-47, (c) 6-OH-BDE-47, and (d) 4’-OH-BDE-49.
wileyonlinelibrary.com/journal/rcmohn Wiley & Sons, Ltd.
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604previously published works, that mixtures of PBDE and OH-
PBDE congeners can be hardly separated within an accepta-
ble run time using conventional C18-based reversed-phase
chromatographic systems. This is particularly true for the
separation of the three nona-BDE isomers and for the separa-
tion of BDE-209 and BDE-206.[25,35,38] Other selectivity factors
such as p–p or dipole–dipole interactions have thus been
considered to achieve the separation of halogenated aromatic
compounds like PBDEs and OH-PBDEs. The use of ~2 mm
particle size packing is known to provide narrower peaks,
which is beneﬁcial for both sensitivity and peak capacity.
Besides, water/methanol mobile phases have been found to
give better results than water/acetonitrile phases, for the
LC/APPI-MS analysis of BFRs by several authors.[33,35–39]
For all these reasons, a 1.9 mm particle size Hypersil Gold
C18 column was compared to a 1.9 mm particle size Hypersil
Gold pentaﬂuorophenyl (PFP) column using water/methanol
mobile phases containing 10% of acetone.
Based on the model mixture used in this work (see Table 1),
the PFP column proved to be more efﬁcient than the C18
column. In particular, the PFP column allowed a greater
retention of the OH-PBDEs which were insufﬁciently
resolved on the C18 column in the presence of acetone in
the mobile phase. Besides, the PFP column also allowed a
separation of BDE-206 to BDE-209 congeners within a shorter
time than the C18 column. A typical chromatogram obtained
from a model PBDE/OH-PBDE mixture using the PFP
column and the optimised methanol/water/acetone gradient
is shown in Fig. 4. The corresponding retention times of each
compound are reported in Table 3. Although some of the
brominated derivatives were not chromatographically
separated (e.g. 5’-OH-BDE-99 and 6-OH-BDE-180), the
detection of all the studied compounds was possible within
ca. 20 min taking advantage of the speciﬁc detection channels
of each compound. The presence of acetone in the LC mobile
phase likely provided an increased selectivity and constituted
a decisive parameter for the separation of BDE-206 and -209
(Fig. 4). Some trials carried out on both C18 and PFP columnsFigure 4. Separation of a PBDE/OH-PBDE mixture (50 pg
on-column each) on a PFP column using optimised conditions:
(a) 3-OH-BDE-47, (b) 6-OH-BDE-47, (c) 4’-OH-BDE-49+3-OH-
BDE-100, (d) 3’-OH-BDE-154+BDE-47, (e) 5’-OH-BDE-99+
6-OH-BDE-180, (f) BDE-100, (g) BDE-154, (h) BDE-99, (i) 4’-OH-
BDE-201, (j) BDE-184, (k) BDE-153, (l) BDE-202, (m) BDE-201,
(n) BDE-204, (o) BDE-208, (p) BDE-207, (q) BDE-206, and
(r) BDE-209.
wileyonlinelibrary.com/journal/rcm Copyright © 2012 John Wiwithout acetone supported this assumption. In a similar way,
Abdallah et al. have developed a LC gradient providing a
complete resolution of those two compounds, likely thanks
to the presence of toluene in their mobile phase.[35]
HRMS method for the identiﬁcation of PBDEs and their
metabolites
Taking into account both the speciﬁc isotopic pattern and
mass defects of polybrominated compounds, we took advan-
tage of the high-resolution mass spectrometry capacities to
develop a method allowing the tracking of both targeted
known metabolites as well as unknown metabolites of
PBDEs. In this context, the use of a high resolution power
(i.e. R = 60 000) was found to be of particular interest in the
case of hydroxylated PBDEs since it allowed discrimination
of [M–H]– ions generated from a given OH-BDE and [M–H–
HBr]– ions generated from an OH-BDE bearing one more
bromine atom. An illustration is given in Fig. 5 representing
the isotopic clusters of the [M–H]– ions of 3-OH-BDE-47
(hydroxylated tetra-BDE, Fig. 5(a)) and the [M–H–HBr]– ions
of 5’-OH-BDE-99 (hydroxylated penta-BDE, Fig. 5(b)). Figures
5(c), 5(d) and 5(e) represent expanded views of the m/z 498.6972
ion (79Br3
81Br isotopomer, theoretical m/z: 498.6997) and the
m/z 498.6803 ion (79Br2
81Br2 isotopomer, theoretical m/z: 498.6820)
ions observed for partially coeluting 6-OH-BDE-47 and 3-OH-
BDE-100, for resolution powers of 15 000, 30 000 and 60 000,
respectively. They indicate that a minimum resolution of 60 000
must be used to allow the complete resolution of these two sig-
nals. However, it is important to note that OH-PBDEs ionised
as [M–Br]– ions still display isotopic clusters rigorously identi-
cal to that of [M–H]– ions produced from OH-PBDEs bearing
one less bromine atom.
In the case of non-hydroxylated PBDEs, the diagnostic ions
monitored were [M–Br+O]– or [M–Br+O–HBr]– ions for both
tetra- and penta-BDEs. For congeners ranging from hexa- to
deca-BDEs, the bromophenoxide ions were monitored as
indicated in Table 3. However, the use of the HRMS full mass
spectra acquisition mode also allowed to check for the
presence of [M–Br]– ions, which are more indicative of the
number of bromine atoms of a given analyte. Moreover, this
acquisition mode enabled to take advantage of the speciﬁc
behaviour of each hydroxylated tetra-PBDE, illustrated in
Fig. 3 and Table 2, and provided an access to additional
signals for unambiguous conﬁrmation of the identities of
the compounds and for the characterization of untargeted
PBDE metabolites (isotopic cluster, mass defect).
Although not developed for quantiﬁcation purposes, the
performances of our LC/APPI-HRMS method (selectivity,
sensitivity) were compared to a reference method, i.e. an
MRM method elaborated on a triple quadrupole instrument
on the same set of reference PBDEs and OH-PBDEs. For the
setup of the MRM method, each transition was selected
taking into account both sensitivity and speciﬁcity. Transitions
used for MRM detection of PBDEs and OH-PBDEs are listed
in Table 3. Owing to their structure, PBDEs and OH-PBDEs
hardly decompose when submitted to collision-induced disso-
ciation (CID) processes. The main decomposition pathway
leads to the non-speciﬁc Br– ions as reported in several studies
dealing with analysis of PBDEs by LC/MS/MS.[36–39] Due to
the lack of other speciﬁc fragmentations, pseudo-transitions
using the same ion as both precursor and product ion wereley & Sons, Ltd. Rapid Commun. Mass Spectrom. 2012, 26, 599–610
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Figure 5. Isotopic clusters of (a) the [M–H]– ions of 3-OH-
BDE-47 and (b) the [M–H–HBr]– ions of 5’-OH-BDE-99.
Expanded view of the m/z=498.7 ions of coeluting 6-OH-
BDE-47 and 3-OH-BDE-100 for resolution powers of (c) 15
000, (d) 30 000, and (e) 60 000.
C. Marteau et al.
606also scheduled. This approach has already been used for the
analysis of compounds without abundant fragmentation and
has proved to provide cleaner chromatograms.[50,51]
The sensitivities of the two methods were then estimated in
terms of limits of detection (LODs, as deﬁned by the injected
amount giving a S/N ratio of 3). Results presented in Table 3
indicate that the two methods showed similar performances
for PBDEs, with LODs ranging from 0.09 to 4.58 pg injected
on-column for LC/HRMS and from 0.18 to 5.95 pg for LC/
MS/MS. These values were in the same range as or better
than those reported for other published methods based on
MRM acquisition on triple quadrupole instruments, with
LODs ranging from 0.11 to 100 pg.[38,39] Surprisingly, due to
higher chemical noise, detection limits for OH-PBDEs wereFigure 6. LC/MS chromatogram of a sample cu
high-resolution acquisition channels (A) m/z 41
(C)m/z 500.698–500.700. Identiﬁedmetabolites are
sulfate, (b, c) tetra-BDE-dihydrodiol glucuronide
hydroxy-tetra-BDE glucuronide, (f) dihydroxy-tetr
(h) OH-tetra-BDE, (i) 6-OH-BDE-47, (j) 5-OH-BDE
wileyonlinelibrary.com/journal/rcm Copyright © 2012 John Wihigher when using MRM compared to HRMS, whereas they
were in the same range for PBDEs (see Table 3). It should also
be noted that the low resolution of quadrupole mass
analyzers did not allow the differentiation of [M–H]– ions
from OH-PBDEs bearing x bromine atoms and [M–H–HBr]–
ions from OH-PBDEs bearing (x + 1) bromine atoms.
To our knowledge, this is the ﬁrst time that OH-PBDEs
have been analysed by LC/APPI-MS. This ionisation mode
proved to be well adapted for those compounds, providing
detection limits in the same range as previously published
works reporting LODs in the pg range using ESI or
APCI,[41,43,44,52] with the ability to track not only targeted
PBDE metabolites (especially OH-PBDEs), but also untargeted
metabolites by tracking speciﬁc signals of brominated species.Application to the identiﬁcation of BDE-47 metabolites
produced by primary cultures of human hepatocytes
The developed method was applied to the identiﬁcation of
metabolites produced in vitro with BDE-47, one of the major
PBDE congeners detected in human samples.[7,8] [14C]-BDE-
47 was incubated for 24 h with human primary cultures of
hepatocytes. From the three separate experiments, the
average rate of metabolism of BDE-47 was 37 6 and 29 8%
for incubations carried out with 1 and 5 mM of BDE-47, respec-
tively. After a cleanup step, culture media were analysed using
our developed LC/APPI-HRMSmethod. Despite an important
inter-individual variability, the obtained metabolic proﬁles
were qualitatively similar. A typical chromatogram resulting
from these analyses is presented in Fig. 6. It exhibits several
peaks detected in particular on the m/z 418.775 (Fig. 6(A)),
m/z 420.790 (Fig. 6(B)) andm/z 500.699 (Fig. 6(C)) channels used
(precision window width: 10 ppm) for APPI detection of
hydroxylated PBDEs as previously discussed. The whole set
of metabolites identiﬁed in this study is listed in Table 4, pre-
senting the diagnostic ions used formetabolite characterisation,
their proposed molecular formula, and the mass deviation
(Δ ppm) with the corresponding calculated accurate mass.
The presence of BDE-47 (14.9 min) and hydroxylated
metabolites could be evidenced on the basis of their respectivelture media analysed on a PFP column, using
8.774–418.776, (B) m/z 420.789–420.791, and
marked as follows: (a) tetra-BDE-dihydrodiol
, (d) dihydroxy-tetra-BDE sulfate, (e) mono-
a-BDE glucuronide, (g) tetra-BDE-dihydrodiol,
-47, and (k) BDE-47.
ley & Sons, Ltd. Rapid Commun. Mass Spectrom. 2012, 26, 599–610
Table 4. BDE-47 metabolites identiﬁed from the incubation of BDE-47 with human hepatocytes. (* correspond to minor meta-
bolites; n.d.: not detected)
Metabolite
Diagnostic ion
molecular formula
Retention
time (min)
Ionisation
technique
Diagnostic ions (m/z)
(most abundant isotopomer)
Δ
ppm
Observed
m/z
Calculated
m/z
Tetra-BDE-dihydrodiol
glucuronide
C18H15O9
79Br2
81Br2 1.7 ESI 694.7397 694.7414 2.45
C12H5O2
79Br2
81Br2 APPI 500.6993 500.6988 1.00
C18H15O9
79Br2
81Br2 2.1 ESI 694.7396 694.7414 2.59
C12H5O2
79Br2
81Br2 APPI 500.6989 500.6988 0.20
Mono-hydroxy-tetra-BDE
glucuronide
C18H13O8
79Br2
81Br2 2.6 ESI 676.7292 676.7308 2.36
C12H5O2
79Br2
81Br2 APPI 500.6992 500.6988 0.80
C18H13O8
79Br2
81Br2 3.3* ESI 676.7288 676.7308 2.96
APPI n.d.
C18H13O8
79Br2
81Br2 3.5 ESI 676.7287 676.7308 3.04
C12H5O2
79Br2
81Br2 APPI 500.6988 500.6988 0.04
Dihydroxy-tetra-BDE
glucuronide
C18H13O9
79Br2
81Br2 3.9* ESI 692.7234 692.7258 3.37
APPI n.d.
C18H13O9
79Br2
81Br2 4.6 ESI 692.7238 692.7258 2.79
C12H5O3
79Br2
81Br2 APPI 516.6942 516.6937 0.97
Tetra-BDE-dihydrodiol sulfate C12H7O6S
79Br2
81Br2 1.2 ESI 598.6643 598.6661 2.61
C12H5O2
79Br2
81Br2 APPI 500.6993 500.6988 1.00
C12H7O6S
79Br2
81Br2 4.1* ESI 598.6667 598.6661 0.78
APPI n.d.
C12H7O6S
79Br2
81Br2 4.3* ESI 598.6667 598.6661 0.78
APPI n.d.
Mono-hydroxy-tetra-BDE
sulfate
C12H5O5S
79Br2
81Br2 2.4 ESI 580.6541 580.6556 2.17
C12H4O2
79Br2
81Br APPI 418.7742 418.7746 0.95
Di-hydroxy-tetra-BDE sulfate C12H5O6S
79Br2
81Br2 2.8 ESI 596.6492 596.6505 1.88
C12H5O3
79Br2
81Br2 APPI 516.6942 516.6937 0.97
Tetra-BDE-dihydrodiol C12H7O3
79Br2
81Br2 7.5 APPI 518.7079 518.7093 2.70
C12H5O2
79Br2
81Br2 500.6974 500.6988 2.80
OH-tetra-BDE C12H5O2
79Br2
81Br2 11.5 APPI 500.6993 500.6988 0.80
C12H4O2
79Br2
81Br 418.7751 418.7746 1.19
6-OH-BDE-47 C12H6O2
79Br2
81Br 13.8 APPI 420.7903 420.7892 2.61
5-OH-BDE-47 C12H4O2
79Br2
81Br 13.9 APPI 418.7746 418.7746 0.01
BDE-47 C12H5O2
79Br81Br 14.9 APPI 340.8639 340.8630 2.63
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60mass spectra and retention times, by comparison with the
authentic standards. Two hydroxylated metabolites were
eluted respectively at 13.8 and 13.9 min. The hydroxylated
metabolite that eluted at 13.8 min (Fig. 6) displayed the same
mass spectrum and retention time as standard 6-OH-BDE-47,
and was mainly evidenced by the occurrence of its correspon-
ding [M–Br]– fragment ion, detected at m/z 420.7903 (most
abundant isotopomer). Therefore, this metabolite was identi-
ﬁed as 6-OH-BDE-47. The retention time and the ionisation
pattern of the hydroxylated metabolite eluted at 13.9 min
(Fig. 6) ﬁtted the chromatographic and mass spectral data of
5-OH-BDE-47, based on the comparison with the authentic
standard. A third hydroxylated tetra-BDE was observed with
a shorter retention time (11.5 min) than that of 3-OH-BDE-47
(12.2 min). Both 6-OH-BDE-47 and 5-OH-BDE-47 result from
the direct hydroxylation of BDE-47. Conversely, the third
hydroxylated tetra-BDE could not correspond to a hydroxy-
BDE-47 since it did not ﬁt LC and MS characteristics of any of
the three possible hydroxylated forms of BDE-47. We assumedCopyright © 2012 JRapid Commun. Mass Spectrom. 2012, 26, 599–610that the formation of this metabolite resulted from a
cytochrome P-450 dependent oxidation, followed by a 1,2-shift
involving the migration of a bromine atom on one of the
proximal carbon atoms of the aromatic ring, as described by
Marsh et al.[53]
The monitoring of speciﬁc masses of OH-PBDEs also indi-
cated the presence of another metabolite, more polar than
the hydroxylated metabolites, which eluted at 7.5 min (Fig. 6)
and actually represented the major metabolite. The highly
informative APPI mass spectrum of this metabolite is shown
in Fig. 7. This spectrum displays an [M–H]– ion centred on
m/z 518.708, togetherwith [M–Cl]– chloride adduct ions (Fig. 7).
Although the occurrence of chloride adduct ions is commonly
observed on atmospheric pressure ionisation mass spectra of
compounds such as amines,[54] their presence on the APPI-
MS spectrum of the BDE-47 metabolites was unexpected
since they have not been observed on any APPI spectrum of
PBDE derivatives previously. On the spectrum presented in
Fig. 7, minor fragment ions are observed at m/z 500.697 andwileyonlinelibrary.com/journal/rcmohn Wiley & Sons, Ltd.
7
Figure 7. Negative APPI mass spectrum and proposed
structure for the BDE-47 metabolite eluted at retention time
7.6 min obtained from the injection of a culture media sample
in LC/APPI-HRMS.
C. Marteau et al.
608438.800, resulting from the loss of H2O and Br, respectively,
whereas the major fragment ion atm/z 420.789 can be attribu-
ted to a [M–Br–H2O]
– species. This spectrum also exhibits
characteristic complementary fragment ions bearing two bro-
mine atoms each, detected at m/z 250.853 and 266.848, whose
origin is attributed to the breakage of the ether bond of the
metabolite according to the scheme proposed in Fig. 7. These
data allowed the identiﬁcation of this metabolite as dihydro-
diol-BDE-47. Taking into account the structure of BDE-47
(2,2’,4,4’-tetrabromodiphenylether), the only possible struc-
ture should correspond to 5,6-dihydrodiol-BDE-47. To our
knowledge, this is the ﬁrst time that this kind of metabolite
has been observed for PBDEs, despite the known formation
of hydroxylated PBDEs,[30,31] dihydroxylated PBDEs,[30] bro-
mophenols,[30,31] and debromination products.[25,53] The for-
mation of such dihydrodiol metabolites has already been
described for other aromatic contaminants such as polycyclic
aromatic hydrocarbons.[55] Taking into account the enzymatic
capability of human hepatocytes, the formation of the dihy-
drodiol metabolite can be explained considering an initial
oxidation of BDE-47 by P450 cytochromes to give an epoxide
intermediate (not identiﬁed), which is then hydrolysed into a
dihydrodiol derivative by epoxide hydrolases.
In addition to those BDE-47 hydroxylated derivatives,
other metabolites, displaying very short retention times
(Fig. 6), yielded mass spectra which also exhibited the speciﬁc
ions of monohydroxylated or dihydroxylated tetra-BDEs. The
complete characterisation of these metabolites needed an
additional LC/HRMS analysis carried out using electrospray
in the negative mode for ionisation. This analysis demon-
strated that these polar compounds were conjugated metabo-
lites of hydroxylated forms of BDE-47, which are listed in
Table 4. Due to the very low amounts available, MS/MS
experiments could not be carried out on these metabolites.
However, these metabolites could be identiﬁed based the
characteristic isotopic mass clusters of their [M–H]– ions, their
exact mass measurement giving access to their elemental
composition, and the occurrence of some characteristic in-
source fragment ions. In particular, in-source fragment ionswileyonlinelibrary.com/journal/rcm Copyright © 2012 John Wicorresponding to the characteristic loss of 176.0318 a.m.u.
for glucuronide conjugates were observed for the metabolites
eluted at 2.1, 2.6, 3.5 and 4.6 min (see Table 4), respectively.
Similarly, diagnostic in-source fragment ions corresponding
to the loss of SO3 (79.9568 a.m.u.) were also observed for
metabolites eluted at 2.4 and 2.8 min (Table 4). All together,
twelve conjugated metabolites were evidenced, out of which
eight were also detected using APPI (see Table 4). Glucuro-
nide and sulfate conjugates of dibromophenol have already
been observed in the urine of rats exposed to BDE-47,[56] as
well as glucuronide and glutathionyl conjugates of BDE-99
in rats.[57] However, to our knowledge, this is the ﬁrst time
that phase II metabolites of intact BDE-47 have been charac-
terised. Furthermore, despite the known formation of
hydroxylated[30,31] and debrominated[53] PBDEs, this study
provides for the ﬁrst time evidence for the formation of a
dihydrodiol metabolite for BDE-47, a structure never charac-
terised before for any PBDE.
In the absence of any standard compound available for
dihydrodiol-BDE-47 as well as for conjugated metabolites,
no precise quantitative information could be used from the
LC/HRMS analyses. However, radio-HPLC analyses allowed
to estimate the relative amounts of the different metabolites.
The major dihydrodiol metabolite accounted for 47 11% of
the total metabolites, while hydroxylated BDE-47 forms
accounted for only 1 2% of the total metabolites in 5 mM
incubations. All together, conjugated metabolites represented
52 10% of the metabolites, based on radioactivity measure-
ments, showing that BDE-47 undergoes both phase I and
phase II metabolism in human hepatocytes.CONCLUSIONS
This work aimed at developing a LC/MS method for the
simultaneous analysis of PBDEs and OH-PBDEs in the
framework of metabolism studies. Three atmospheric pres-
sure ionisation modes were compared and APPI was selected
for its sensitivity. In addition, APPI was shown to provide key
information for the identiﬁcation of these compounds,
including speciﬁc ionisation patterns for different isomeric
hydroxylated PBDEs. The optimisation of APPI parameters
showed that the dopant is not the only important parameter
to take into account for PBDEs ionisation, and the operating
temperatures should also be carefully adjusted to maximise
the sensitivity. The use of an Orbitrap mass spectrometer
highlighted the great usefulness of high resolution power
(60 000) for the differentiation of diagnostic ions which may
overlap, due to the isotopic patterns of these polybrominated
compounds. The high-resolution full-scan acquisition mode
was an additional critical advantage of the method, since it
provided access not only to targeted compounds, but also to
non-targeted metabolites, without any loss of sensitivity.
The method was applied to the identiﬁcation of BDE-47
metabolites produced by human hepatocytes, and proved to
be efﬁcient for the monitoring of the parent compounds as
well as for the identiﬁcation of the main known PBDEs
metabolites, namely hydroxylated PBDEs. A novel metabo-
lite, namely BDE-47 dihydrodiol, was characterised in this
work. The APPI method can also be used to monitor
conjugated metabolites, even though ESI was required to give
access to their quasi-molecular ions for unambiguousley & Sons, Ltd. Rapid Commun. Mass Spectrom. 2012, 26, 599–610
Determination of PBDEs and their metabolitesidentiﬁcation purposes. The developed method is suitable for
the simultaneous identiﬁcation and/or monitoring of PBDEs
and their metabolites. Applications to other metabolism stu-
dies, and to the analysis of biological samples such as serum
or maternal milk, can now be foreseen.Acknowledgements
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